Hershberger Assays for Bisphenol-A and Its Substitute Candidates
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Bisphenol-A(BPA) is a member of alkylphenol family, and shows adverse effects including reduced fertility, reproductive tract abnormalities, metabolic disorder, cancer induction, neurotoxicity and immunotoxicity. In the present study, we conducted Hershberger assay to evaluate whether the two candidates to replace BPA have androgenic or antiandrogenic ac-tivity. The assay was carried out using immature castrated Sprague–Dawley male rats. After 7 days of the surgery, testosterone propionate (TP, 0.4 mg/kg/day) and test materials (low dose, 40 mg/kg/day; high dose, 400 mg/kg/day) were administered for 10 consecutive days by subcutaneous (s.c.) injection and oral gavage, respectively. Test materials were BPA, isosorbide (ISO) and cyclohexanedimethanol (CHDM). The rats were necropsied, and then the weights of five androgen-dependent tissues [ventral prostate, seminal vesicle, levator ani-bulbocavernosus (LABC) muscle, paired Cowper’s glands, and glans penis] and three androgen-insensitive tissues (kidney, spleen and liver) were measured. All test materials including BPA did not exhibit any androgenic activity in the assay. On the contrary, antiandrogen-like activities were found in all test groups, and the order of the intensity was CHDM > BPA > ISO in the five androgen-sensitive tissues. There was no statistical difference between low dose treatment and high dose treatment of BPA group as well as ISO group. In CHDM group, high dose treatment exhib-ited most severe weight reduction in all measured tissues. There was no statistical difference in androgen-insensitive tissue measurements, except BPA groups. Since the effects of ISO treatment on the accessory sex organs were much less or not pre-sent at all when compared to those of BPA, ISO could be a strong candidate to replace BPA. CHDM treatment brought most severe weight reduction in all of androgen-sensitive tissues, so this material should be excluded for further screening of BPA substitute selection.
Abstract
Bisphenol-A(BPA) is a member of alkylphenol family, and shows adverse effects including reduced fertility, reproductive tract abnormalities, metabolic disorder, cancer induction, neurotoxicity and immunotoxicity. In the present study, we conducted Hershberger assay to evaluate whether the two candidates to replace BPA have androgenic or antiandrogenic ac-tivity. The assay was carried out using immature castrated Sprague–Dawley male rats. After 7 days of the surgery, testosterone propionate (TP, 0.4 mg/kg/day) and test materials (low dose, 40 mg/kg/day; high dose, 400 mg/kg/day) were administered for 10 consecutive days by subcutaneous (s.c.) injection and oral gavage, respectively. Test materials were BPA, isosorbide (ISO) and cyclohexanedimethanol (CHDM). The rats were necropsied, and then the weights of five androgen-dependent tissues [ventral prostate, seminal vesicle, levator ani-bulbocavernosus (LABC) muscle, paired Cowper’s glands, and glans penis] and three androgen-insensitive tissues (kidney, spleen and liver) were measured. All test materials including BPA did not exhibit any androgenic activity in the assay. On the contrary, antiandrogen-like activities were found in all test groups, and the order of the intensity was CHDM > BPA > ISO in the five androgen-sensitive tissues. There was no statistical difference between low dose treatment and high dose treatment of BPA group as well as ISO group. In CHDM group, high dose treatment exhib-ited most severe weight reduction in all measured tissues. There was no statistical difference in androgen-insensitive tissue measurements, except BPA groups. Since the effects of ISO treatment on the accessory sex organs were much less or not pre-sent at all when compared to those of BPA, ISO could be a strong candidate to replace BPA. CHDM treatment brought most severe weight reduction in all of androgen-sensitive tissues, so this material should be excluded for further screening of BPA substitute selection.
참고문헌 (29)
- Björnsdotter MK, "Bisphenol A and replacements in thermal paper: A review", Chemosphere, 182, pp.691~706 (2017)
- Costa EM, "Effects of endocrine disruptors in the development of the female reproductive tract", Arq Bras Endocrinol Metabol, 58, pp.153~161 (2014)
- Devillers J, "SAR and QSAR modeling of endocrine disruptors", SAR QSAR Environ Res, 17, pp.393~412 (2006)
- Dickerson SM, "Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle", Rev Endocr Metab Disord, 8, pp.143~159 (2007)
- Eladak S, "A new chapter in the bisphenol A story : bisphenol S and bisphenol F are not safe alternatives to this compound", Fertil Steril, 103, pp.11~21 (2015)
- Giulivo M, "Human exposure to endocrine disrupting compounds:Their role in reproductive systems, metabolic syndrome and breast cancer. A review", Environ Res, 151, pp.251~264 (2016)
- EDSP, "Endocrine Disruptor Screening Program (EDSP) Hershberger Assay OCSPP Guideline 890.1400 Standard Evaluation Procedure (SEP)", US Environmental Protection Agency, ~ (1998)
- Ho SM, "Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4", Cancer Res, 66, pp.5624~5632 (2006)
- Itoh K, "Bisphenol A, an endocrine-disrupting chemical, and brain development", Neuropathology, 32, pp.447~457 (2012)
- Karwacka A, "Exposure to modern, widespread environmental endocrine disrupting chemicals and their effect on the reproductive potential of women: an overview of current epidemiological evidence", Hum Fertil (Camb), 31, pp.1~24 (2017)
- Kim HS, "No androgenic", anti-androgenic effects of bisphenol-A in Hershberger assay using immature castrated rats, 2002, pp.135, 111~123
- Kimber I, "Bisphenol A and immunotoxic potential:A commentary", Regul Toxicol Pharmacol, 90, pp.358~363 (2017)
- McLachlan JA, "Environmental signaling: from environmental estrogens to endocrine-disrupting chemicals and beyond", Andrology, 4, pp.684~694 (2016)
- Harry MacKay, "A plurality of molecular targets: The receptor ecosystem for bisphenol-A (BPA)", Hormones and Behavior (2017), Elsevier BV[DOI]
- Manfo FP, "Adverse effects of bisphenol A on male reproductive function", Rev Environ Contam Toxicol, 228, pp.57~82 (2014)
- Marty MS, "Key learnings from the Endocrine Disruptor Screening Program (EDSP) Tier 1rodent uterotrophic and Hershberger assays", Birth Defects Res B Dev Reprod Toxicol, 101, pp.63~79 (2014)
- Meeker JD, "Exposure to environmental endocrine disruptors and child development", Arch Pediatr Adolesc Med, 166, pp.952~958 (2012)
- Nimrod AC, "Environmental estrogenic effects of alkylphenol ethoxylates", Crit Rev Toxicol, 26, pp.335~364 (1996)
- Nishino T, "The xenoestrogen bisphenol A in the Hershberger assay: androgen receptor regulation and morphometrical reactions indicate no major effects", J Steroid Biochem Mol Biol, 98, pp.155~163 (2006)
- OECD, "OECD test guideline 440 uterotrophic bioassay in rodents: a short-term screening test for oestrogenic properties", ~ (2007)
- OECD, "Draft OECD guideline for the testing of chemicals. The Hershberger bioassay in rats: A short term test for (anti) androgenic properties", ~ (2008)
- Pivnenko K, "Bisphenol A and its structural analogues in household waste paper", Waste Manag, 44, pp.39~47 (2015)
- Richter CA, "In vivo effects of bisphenol A in laboratory rodent studies", Reprod Toxicol, 24, pp.199~224 (2007)
- Rochester JR, "Bisphenol S and F: A systematic review and comparison of the hormonal activity of bisphenol a substitutes", Environ Health Perspect, 123, pp.643~650 (2015)
- Rubin BS, "Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects", J Steroid Biochem Mol Bio, 127, pp.27~34 (2011)
- Sifakis S, "Human exposure to endocrine disrupting chemicals: Effects on the male and female reproductive systems", Environ Toxicol Pharmacol, 51, pp.56~70 (2017)
- Teng C, "Bisphenol A affects androgen receptor function via multiple mechanisms", Chem Biol Interact, 203, pp.556~564 (2013)
- WHO, "State of the science of endocrine disrupting chemicals - 2012" (2013), World Health Organization
- Yoon K, "Estrogenic endocrine-disrupting chemicals: molecular mechanisms of actions on putative human diseases", J Toxicol Environ Health B Crit Rev, 17, pp.127~174 (2014)